In our study, we treated HCT-116 and DLD-1 colorectal cancer cell lines with low SVCT2 expression with VPA (0.25–2 mM) for 48 h and determined the expression levels of the SVCT2 gene and protein. The gene discussed is SLC23A2; the disease is colorectal cancer.